Search results

NICE is committed to involving people who use services, carers and the public in the development of our guidance and other products.

This quality standard covers diagnosing and managing endometriosis in women and people, including those aged 17 and under. It describes high-quality care in priority areas for improvement.

Result type

Quality standard

Published

6 August 2018

Evidence-based recommendations on mirikizumab (Omvoh) for treating moderately to severely active ulcerative colitis in adults.

Result type

Technology appraisal guidance

Published

25 October 2023

Evidence-based recommendations on bevacizumab gamma (Lytenava) for treating wet age-related macular degeneration in adults.

Result type

Technology appraisal guidance

Published

4 December 2024

people's weight or improved how well-nourished they were. It is not possible to know in advance what will happen to any individual...

This guideline covers recognising and responding to abuse and neglect in children and young people aged under 18. It covers physical, sexual and emotional abuse, and neglect. The guideline aims to help anyone whose work brings them into contact with children and young people to spot signs of abuse and neglect and to know how to respond. It also supports practitioners who carry out assessments and provide early help and interventions to children, young people, parents and carers.

Result type

NICE guideline

Published

9 October 2017

We are listening to your views on this Health technology evaluation. Comments close 24 February 2026.

Result type

Health technology evaluation

Status

In consultation

This quality standard covers managing acute painful episodes of sickle cell disease in hospital. It includes pain relief and care for children, young people and adults, from presentation in hospital until discharge. It describes high-quality care in priority areas for improvement.

Result type

Quality standard

Published

10 April 2014

Evidence-based recommendations on obinutuzumab (Gazyvaro) with bendamustine for follicular lymphoma that has not responded or has progressed up to 6 months after treatment with rituximab or a rituximab-containing regimen in adults.

Result type

Technology appraisal guidance

Published

13 May 2020

NICE content assurance service

We assess the efficacy and safety of interventional procedures used for treatment or diagnosis to determine whether they work well enough and are safe enough for use in the NHS.

receive email updates on interventional procedures guidance. We'll let you know when: you can comment on draft recommendations the final...

This quality standard covers identifying, assessing and regularly reviewing the care and support needs of people with a learning disability as they grow older. People with a learning disability have many of the same age-related health and social care needs as other people, but this quality standard focuses on the specific challenges associated with their learning disability. It describes high-quality care in priority areas for improvement.

Result type

Quality standard

Published

24 July 2019

This guideline covers how to identify adults at high risk of type 2 diabetes. It aims to remind practitioners that age is no barrier to being at high risk of, or developing, the condition. It also aims to help them provide those at high risk with an effective and appropriate intensive lifestyle-change programme to prevent or delay the onset of type 2 diabetes. The recommendations in this guideline can be used alongside the NHS Health Check programme .

Result type

Public health guideline

Last updated

15 September 2017

This quality standard covers diagnosing, assessing and managing cerebral palsy in children and young people under 25. It describes high-quality care in priority areas for improvement.

Result type

Quality standard

Published

10 October 2017